Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Did I read correctly.....
Stockholders’ equity:
               
Preferred stock, $0.00001 par value; 5,000,000 shares authorized: none outstanding
   
-
     
-
 
Common stock, $0.00001 par value: 500,000,000 shares authorized: 410,638,449 shares issued and 391,472,101 shares outstanding at November 30, 2007 and 406,668,661 shares issued and 393,201,134 shares outstanding at May 31, 2007

 

Share
New Message
Please login to post a reply